China approves Sinopharm, Sinovac to be used on children between 12 and 17 yrs



China has stated the use of its Sinopharm and Sinovac vaccines for the inoculation of children between 12 and 17 years, the Chinese Embassy says.


The Embassy says more than 160 million doses of vaccines had been administered among pupils aged 12-17 across China  by September 6.



  Comments - 0


You May Also Like